Scientists at a biotech company report creating two gene-edited beagles intended to be hypoallergenic for people with dog allergies. According to the coverage, the dogs are engineered to alter factors associated with allergic reactions, so they may be less likely to trigger symptoms in sensitized individuals. The reports describe the work as an early step toward a potential long-term option for people who want to live with dogs but cannot tolerate conventional pets due to allergy. The articles characterize the development as research still in progress, with additional evaluation needed before any broader conclusion about effectiveness and safety can be drawn. While the studies focus on reducing allergy-causing responses, the reporting emphasizes that this approach is experimental and not yet available as a real-world solution. The two outlets present the same core claim: gene editing is used to produce beagles that are designed to reduce allergic triggers, suggesting a possible future pathway for addressing dog-related allergies.